OA
Orbimed Advisors LLC cut its PYXS stake below 5%
Orbimed Advisors LLC reported owning 3.6% of Pyxis Oncology, Inc. (PYXS) (4,348,197 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.